Qiagen
In Brief This Week: Qiagen, Mainz Biomed, Quest Diagnostics, Haystack Oncology, Becton Dickinson
News items for the week of June 19, 2023
Digital PCR's strengths make the technology well positioned to aid biopharma companies in cell and gene therapy development and manufacturing.
Qiagen Q1 Revenues Fall 23 Percent but Exceed Outlook, Analyst Estimates
Qiagen also reported double-digit growth at constant exchange rates in its non-COVID product groups.
People in the News at Integrated DNA Technologies, AdvaMedDx, Waters, Pacific Edge
Executive and academic appointments, promotions, and departures in omics and molecular diagnostics for the week of March 27, 2023.
Servier, Qiagen to Develop PCR-Based Companion Diagnostic to Identify IDH1-Mutant Leukemia
Qiagen will develop a real-time PCR-based in vitro diagnostic to identify patients eligible for Servier's Tibsovo and investigational IDH1-targeted agents.
May 17, 2022